| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pemetrexed | FAERS: 2 | OFFSIDES US FAERS | |
| 2 | gemcitabine | FAERS: 2 | US FAERS | |
| 3 | Capecitabine | FAERS: 1 | US FAERS | |
| 4 | Crizotinib | FAERS: 1 | US FAERS | |
| 5 | Ibuprofen | FAERS: 1 | US FAERS | |
| 6 | Medroxyprogesterone Acetate | FAERS: 1 | US FAERS | |
| 7 | Phenytoin | FAERS: 1 | US FAERS | |
| 8 | Sunitinib | FAERS: 1 | US FAERS | |
| 9 | Temozolomide | FAERS: 1 | US FAERS | |
| 10 | ambrisentan | FAERS: 1 | US FAERS | |
| 11 | Bleomycin | OFFSIDES | ||
| 12 | Flucytosine | OFFSIDES | ||
| 13 | spironolactone, althiazide drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.